Global Bullous Keratopathy Market Outlook 2023-2032: Emerging Therapies like VYZNOVA (Neltependocel) Offer Hope Amidst Limited Treatment Options
August 22, 2023 07:03 ET
|
Research and Markets
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Global Bullous Keratopathy Market Outlook 2023-2032 report has been added to ResearchAndMarkets.com's offering. This report presents comprehensive...
Global Dry Eye Medication Market Research Report 2021
July 15, 2021 08:08 ET
|
Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Dry Eye Medication Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...
Global Antiglaucoma Drugs Market Research Report 2021
July 15, 2021 06:48 ET
|
Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Antiglaucoma Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Global Ophthalmology Drugs Market Report 2021-2030 Featuring Novartis AG; F. Hoffmann-La Roche Ltd; Allergan Plc; Valeant Pharmaceuticals Intl Inc and Bayer
March 30, 2021 04:03 ET
|
Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Ophthalmology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. Major...
Global Antiglaucoma Drugs Market Report 2020-2030: Top 8 Competitors Account for 44% of the Total Market in 2019 - Major Players are Allergen, Novartis, Santen Pharmaceuticals, Akorn and Pfizer
February 03, 2021 05:33 ET
|
Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Antiglaucoma Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...